Literature DB >> 16982178

Reversed chitosan-alginate polyelectrolyte complex for stability improvement of alpha-amylase: optimization and physicochemical characterization.

Mayur G Sankalia1, Rajashree C Mashru, Jolly M Sankalia, Vijay B Sutariya.   

Abstract

The present work explores, using response surface methodology, the main and interaction effects of some process variables on the preparation of a reversed chitosan-alginate polyelectrolyte complex (PEC) with entrapped alpha-amylase for stability improvement. A 3(3) full factorial design was used to investigate the effect of the chitosan and alginate concentrations and hardening time on the percent entrapment, time required for 50% (T(50)) and 90% (T(90)) enzyme release, and particle size. The beads were prepared by dropping chitosan containing alpha-amylase into a sodium alginate solution without any salt. The in vitro enzyme release profile of the beads was fitted to various release kinetics models to study the release mechanism. A topographical characterization was carried out using scanning electron microscopy (SEM), and the entrapment was confirmed using Fourier transform infrared (FTIR) spectroscopy and differential scanning calorimetry (DSC). Stability testing was carried out according to the International Conference on Harmonization (ICH) guidelines for zones III and IV. Beads prepared using 2.5%w/v chitosan and 3%w/v sodium alginate with a hardening time of 60 min had more than 90% entrapment and a T(90) value greater than 48 min. Moreover, the shelf-life of the enzyme-loaded beads was found to increase to 3.68 years, compared with 0.99 years for the conventional formulation. It can be inferred that the proposed methodology can be used to prepare a reversed PEC of chitosan and alginate with good mechanical strength, provided both the reactants are in a completely ionized form at the time of the reaction. Proper selection of the reaction pH, polymer concentration and hence charge density, and hardening time is important and determines the characteristics of the PEC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16982178     DOI: 10.1016/j.ejpb.2006.07.014

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  27 in total

1.  Improved antifilarial activity of ivermectin in chitosan-alginate nanoparticles against human lymphatic filarial parasite, Brugia malayi.

Authors:  Mohammad Ali; Mohammad Afzal; Meenakshi Verma; Shailja Misra-Bhattacharya; Farhan Jalees Ahmad; Amit Kumar Dinda
Journal:  Parasitol Res       Date:  2013-07-05       Impact factor: 2.289

2.  Formulation, Pharmacokinetics evaluation, and IVIVC Assessment of Gliclazide Multiparticulates in Rat Model.

Authors:  Ahmed A El-Ashmawy; Aya R Abdou; Nesrin F Taha; Ebtesam W Elsayed; Khaled M Mahmoud; Laila H Emara
Journal:  AAPS PharmSciTech       Date:  2021-04-30       Impact factor: 3.246

Review 3.  A review of polymeric refabrication techniques to modify polymer properties for biomedical and drug delivery applications.

Authors:  Viness Pillay; Ahmed Seedat; Yahya E Choonara; Lisa C du Toit; Pradeep Kumar; Valence M K Ndesendo
Journal:  AAPS PharmSciTech       Date:  2013-03-30       Impact factor: 3.246

Review 4.  Chitosan based polyelectrolyte complexes as potential carrier materials in drug delivery systems.

Authors:  Josias H Hamman
Journal:  Mar Drugs       Date:  2010-04-19       Impact factor: 5.118

5.  Hybrid drug delivery system for oropharyngeal, cervical and colorectal cancer - in vitro and in vivo evaluation.

Authors:  Mohamed S Pendekal; Pramod K Tegginamat
Journal:  Saudi Pharm J       Date:  2012-08-11       Impact factor: 4.330

6.  Tannic acid incorporation in chitosan-based microparticles and in vitro controlled release.

Authors:  Neculai Aelenei; Marcel Ionel Popa; Ovidiu Novac; Gabriela Lisa; Lacramioara Balaita
Journal:  J Mater Sci Mater Med       Date:  2009-01-22       Impact factor: 3.896

7.  Chitosan and alginate polyelectrolyte complex membranes and their properties for wound dressing application.

Authors:  Xin Meng; Feng Tian; Jian Yang; Chun-Nian He; Nan Xing; Fan Li
Journal:  J Mater Sci Mater Med       Date:  2010-01-26       Impact factor: 3.896

8.  Development and characterization of chitosan-polycarbophil interpolyelectrolyte complex-based 5-fluorouracil formulations for buccal, vaginal and rectal application.

Authors:  Mohamed S Pendekal; Pramod K Tegginamat
Journal:  Daru       Date:  2012-10-25       Impact factor: 3.117

9.  Chitosan-alginate nanoparticles as a novel drug delivery system for nifedipine.

Authors:  Ping Li; Ya-Ni Dai; Jun-Ping Zhang; Ai-Qin Wang; Qin Wei
Journal:  Int J Biomed Sci       Date:  2008-09

10.  Development of novel cationic chitosan-and anionic alginate-coated poly(D,L-lactide-co-glycolide) nanoparticles for controlled release and light protection of resveratrol.

Authors:  Vanna Sanna; Anna Maria Roggio; Silvia Siliani; Massimo Piccinini; Salvatore Marceddu; Alberto Mariani; Mario Sechi
Journal:  Int J Nanomedicine       Date:  2012-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.